GlaxoSmithKline (LSE:GSK)
GlaxoSmithKline is one of the world's leading pharmaceutical research companies. The company was created out of the merger between GlaxoWellcome and SmithKline Beecham in 2000.
{{ formattedPrice }} {{ change }} (-0.15%)
Quotes delayed. Last trade: 14-12-2018, 04:39:10pm GMT
| Open Price | {{ openPrice }} | Close Price | {{ closePrice }} |
| Day High | {{ high }} | Day Low | {{ low }} |
| Bid | {{ bid }} | Ask | {{ ask }} |
| Volume | 6679525 |
Related Articles
-
Why the GSK share price is a FTSE 100 dividend growth opportunity I’d buy today
GlaxoSmithKline plc (LON: GSK) could offer better income investing potential than the FTSE 100 (INDEXFTSE: UKX). Read More »
-
Are the BT and GlaxoSmithKline share prices the best FTSE 100 dividend choices?
Royston Wild considers whether BT Group plc (LON: BT-A) or GlaxoSmithKline plc (LON: GSK) is the superior FTSE 100 (INDEXFTSE: UKX) dividend share. Read More »
-
Should you buy the GSK share price after last week’s 10% fall?
Roland Head updates his rating on GlaxoSmithKline plc (LON:GSK) following news of two big deals. Read More »
-
Thinking of buying the GlaxoSmithKline share price? Read this first
GlaxoSmithKline plc (LON: GSK) might look cheap, but there's a reason why the market is dumping the company says Rupert Hargreaves. Read More »
-
Why I’d snap up the GSK share price for Christmas
I think the GlaxoSmithKline plc (LON: GSK) share price is lagging behind the turnaround in the company's fortunes. Read More »
-
3 top dividend stocks I’d buy right now
Could these big dividend-paying stocks help investors grow their wealth even during the final Brexit negotiations? Read More »
-
Forget the best easy-access savings rate. I’d pick up a 5.1% yield with GSK shares
You could earn 1.5% from a savings account, or you could pick up 5.1% from GlaxoSmithKline plc (LON: GSK) shares, explains Edward Sheldon. Read More »
-
3 FTSE 100 shares I’d buy right now in this fallen market
Why these FTSE 100 (INDEXFTSE:UKX) firms sit firmly on my ‘buy’ list. Read More »
-
Is GlaxoSmithKline a screaming buy after this news?
Following the results of a landmark drug trial, GlaxoSmithKline plc (LON: GSK) could be a screaming buy, says Rupert Hargreaves. Read More »
-
The GSK share price has soared 15%. Here’s why I think the FTSE 100 stock can’t be ignored
GlaxoSmithKline plc (LON: GSK) could offer stronger prospects than the FTSE 100 (INDEXFTSE: UKX). Read More »
